17th September 2021
Dilawar Khokhar, Cem Akin (2020). This article discusses the complexity of diagnosing mast cell activation syndrome (MCAS) due to nonspecific symptoms, heterogeneity of presentation, and limitations to diagnostic criteria. It emphasizes the need for a systematic, evidence-based diagnostic approach to avoid misdiagnosis, unnecessary testing, and ineffective treatment.
Sign up to become a Friend of Mast Cell Action so we can keep you up to date on our progress and on how to get involved in our latest campaigns and initiatives.
Mast Cell Action relies entirely on the generosity of people like you. Please make a donation now and together we can make a difference to those affected by MCAS.